✦ LIBER ✦

Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma

✍ Scribed by Jaafar Bennouna; Emmanuelle Bompas; Eve Marie Neidhardt; Frédéric Rolland; Irène Philip; Céline Galéa; Samuel Salot; Soraya Saiagh; Marie Audrain; Marie Rimbert; Sylvie Lafaye-de Micheaux; Jérôme Tiollier; Sylvie Négrier

Publisher: Springer-Verlag
Year: 2008
Tongue: English
Weight: 495 KB
Volume: 57
Category: Article
ISSN: 0340-7004
DOI: 10.1007/s00262-008-0491-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II study of adoptive transfer of

Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma

✍ Hirohito Kobayashi; Yoshimasa Tanaka; Junji Yagi; Nagahiro Minato; Kazunari Tana 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 674 KB

Phase I/II study of thalidomide in combi

Phase I/II study of thalidomide in combination with interleukin-2 in patients with metastatic renal cell carcinoma

✍ Robert J. Amato; Margaret Morgan; Anish Rawat 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Phase I study of bromohydrin pyrophospha

Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vγ9Vδ2 T lymphocyte agonist in patients with solid tumors

✍ Jaafar Bennouna; Vincent Levy; Hélène Sicard; Hélène Senellart; Marie Audrain; S 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 322 KB